Switch to:
More From Other Websites
Cramer Remix: A bottom in biotech? Hardly Mar 27 2015
Cramer: 4 horsemen of biotech & semis are back Mar 27 2015
Stocks Finish Lower for the Week as Fed Talk Spooks Investors Mar 27 2015
11 promising drugs poised to be the next billion-dollar blockbusters Mar 27 2015
Regeneron's Eylea Gets FDA Approval for Label Expansion - Analyst Blog Mar 26 2015
Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks Mar 26 2015
Dow tumbles 292 points as economy shows cracks Mar 25 2015
In A Genetic Portrait Of A Nation, A Map Of The Future Mar 25 2015
Biotechs On Track For Worst Week In A Year Mar 25 2015
EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in... Mar 25 2015
EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in... Mar 25 2015
Lightning Round: Problem with Visa's split Mar 24 2015
Bristol, Sanofi and Novartis drugs to shine among 2015 launches Mar 23 2015
Bristol, Sanofi and Novartis drugs to shine among 2015 launches Mar 23 2015
Actavis' Wide-Moat Transformation Offers Shareholder Rewards Mar 23 2015
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 23 2015
Bristol, Sanofi and Novartis drugs to shine among 2015 launches Mar 22 2015
Don't-Buy Call on Biotech; Oil Pipeline: Jim Cramer's Best Blogs Mar 21 2015
Cramer Remix: Cha-ching! Time to cash in Mar 20 2015
Cramer's don't buy call: REGN & BIIB Mar 20 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK